Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ: EXAS )

48.50 -1.68 (-3.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
How Is The Market Feeling About Exact Sciences?
Via Benzinga
Exact Sciences to Participate in June Investor Conferences
From Exact Sciences Corp.
Via Business Wire
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
We're heading into our third year of this raging bull market, and there doesn't appear to be any end in sight for these high-return stocks. 
Via InvestorPlace
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
The companies are likely to soon battle it out in the colon cancer screening market. 
Via Investor's Business Daily
Exposures Product Safety
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Earns 2024 Great Place To Work® Certification™
From Exact Sciences Corp.
Via Business Wire
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
From Exact Sciences Corp.
Via Business Wire
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential. 
Via InvestorPlace
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising uptick in unemployment claims prompting speculation over Federal Reserve... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
Via InvestorPlace
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
EXAS Stock Earnings: Exact Sciences Misses EPS, Beats Revenue for Q1 2024
EXAS stock results show that Exact Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a quarterly... 
Via Benzinga
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
The company reported better-than-expected sales, but losses widened and missed forecasts. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Exact Sciences Announces First-Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Stocks Falter As Fed Signals Need For Higher-For-Longer Rates; Uber Crashes, Energy Sector Loses Ground: What's Driving Wednesday's Market?
Wednesday witnessed a tempering of the bullish sentiment that had buoyed Wall Street in recent sessions, with major indices showing slight declines around midday trading in New York. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High
U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more speeches by Federal Reserve officials. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
From Exact Sciences Corp.
Via Business Wire
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far. 
Via Benzinga
Topics Stocks
Exposures US Equities
Exact Sciences to Participate in May Investor Conference
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
From Exact Sciences Corp.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.